1. Adoptive immunotherapy with double‐bright (CD56bright/CD16bright) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof‐of‐concept study. (7th September 2021) Authors: Silla, Lucia; Valim, Vanessa; Pezzi, Annelise; da Silva, Maria; Wilke, Ianae; Nobrega, Juliana; Vargas, Alini; Amorin, Bruna; Correa, Bruna; Zambonato, Bruna; Scherer, Fernanda; Merzoni, Joice; Sekine, Leo; Huls, Helen; Cooper, Laurence J.; Paz, Alessandra; Lee, Dean A. Journal: British journal of haematology Issue: Volume 195:Number 5(2021) Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗